Not by vaccine alone
Last year, India's genetic drug manufacturers slashed the cost of their anti-retroviral drugs which provided thousands of Aids patients with the chance to live longer and more productive lives. Now
Related Content
- Progress and challenges with achieving universal immunization coverage
- Vaccination alone unlikely to end Gorakhpur deaths
- Anti-obesity injections: Good or bad?
- WORLD CANCER DAY 2015:GLOBAL PRESS RELEASE
- Transport networks and inequities in vaccination: remoteness shapes measles vaccine coverage and prospects for elimination across Africa
- Yellow Fever in Africa: Estimating the burden of disease and impact of mass vaccination from outbreak and serological data